Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00698
|
|||||
| Drug Name |
Naloxone
|
|||||
| Synonyms |
(-)-N-allyl-14-hydroxynordihydroxymorphinan-6-one; (-)-Naloxone; (5alpha)-3,14-dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one; (5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one; 1-N-Allyl-14-hydroxynordihydromorphinone; 1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone; 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone; 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one; 17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one; 17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one; 17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one; 3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5alpha-epoxymorphinan-6-one; DBL Naloxone; DBL Naloxone (TN); EN 1530base; L-N-Allyl-14-hydroxynordihydromorphinone; L-N-Allyl-7,8-dihydro-14-hydroxynormorphinone; L-Naloxone; Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy-(8CI); Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)-(9CI); N-Allyl-4,5alpha-epoxy-3,14-dihydroxy-6-morphinanon; N-Allyl-noroxymorphone; N-Allylnoroxymorphone; Nalone; Nalone (TN); Nalossone; Nalossone [DCIT]; Naloxona; Naloxona [INN-Spanish]; Naloxone (INN); Naloxone HCl; Naloxone [INN:BAN]; Naloxonum; Naloxonum [INN-Latin]; Narcan; Narcan (TN); Narcanti; Narcanti (TN); Narcon
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antinarcotic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H21NO4
|
|||||
| Canonical SMILES |
C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
|
|||||
| InChI |
InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19+/m1/s1
|
|||||
| InChIKey |
UZHSEJADLWPNLE-FCLVOEFKSA-N
|
|||||
| CAS Number |
CAS 465-65-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 327.4 | Topological Polar Surface Area | 70 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
2.1
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| ChEBI ID |
ChEBI:7459
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.